Recent Updates
-
Updated on: Dec 07, 2022
NQF 0074 (Additional): Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol
Measure: NQF 0074 (Additional Measure)
Measure Title: Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol
Measurement Description: Percentage of patients aged 18 years and older with a diagnosis of CAD who were prescribed a lipid-lowering therapy (based on current ACC/AHA guidelines).
*REQUIRED FOR MEANINGFUL USE (MU): Click here to view the Meaningful Use Criteria.
-
Updated on: Dec 07, 2022
NQF 0014 (Additional): Prenatal Care - Anti-D Immune Globulin
Measure: NQF 0014 (Additional Measure)
Measure Title: Prenatal Care: Anti-D Immune Globulin
Measure Description: Percentage of D (Rh) negative, unsensitized patients, regardless of age, who gave birth during a 12-month period who received anti-D immune globulin at 26-30 weeks gestation.
-
Updated on: Dec 07, 2022
(DRAFT) *NQF 0036 (Additional): Use of Appropriate Medications for Asthma
THIS LESSON IS CURRENTLY A DRAFT AND IS NOT YET COMPLETE
Measure: NQF 0036 (Additional Measure)
Measure Title: Use of Appropriate Medications for Asthma
Measure Description: Percentage of patients 5 - 50 years of age whom were identified as having persistent asthma, had at least one face-to-face encounter and were appropriately prescribed medication during the reporting period. Report three age stratification's (5-11 years, 12-50 years, and total).
*REQUIRED FOR MEANINGFUL USE (MU) ADDITIONAL QM MEASURE: Click here to view Meaningful Use Criteria.
-
Updated on: Dec 07, 2022
NQF 0389 (Additional): Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
Measure: NQF 0389 (Additional Measurement)
Measure Title: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
Measure Description: Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy whom did not have a bone scan performed at any time since diagnosis of prostate cancer.
-
Updated on: Dec 07, 2022
NQF 0056 (Additional) Diabetes: Foot Exam
Measure: NQF 0056 (Additional Measure)
Measure Title: Diabetes: Foot Exam
Measure Description: The percentage of patients aged 18 - 75 years with diabetes (Type 1 or Type 2) whom had a foot exam (visual inspection, sensory exam with mono filament, or pulse exam).
*REQUIRED FOR MEANINGFUL USE (MU) ADDITIONAL MEASURE: Click here to view the Meaningful Use Criteria.
-
Updated on: Dec 07, 2022
NQF 0068 (Additional) - Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
Measure: NQF 0068 (Additional Measure)
Measure Title: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
Measure Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1-November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had documentation of use of aspirin or another antithrombotic during the measurement year.
*REQUIRED FOR MEANINGFUL USE (MU): Click here to view the Meaningful Use Criteria.
-
Updated on: Dec 07, 2022
NQF 0018 (Additional): Controlling High Blood Pressure
Measure: NQF 0018 (Additional Measure)
Measure Title: Controlling High Blood Pressure
Measure Description: The percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose BP was adequately controlled during the measurement year.
-
Updated on: Dec 07, 2022
(DRAFT) NQF 0052 (Additonal) Low Back Pain: Use of Imaging Studies
THIS LESSON IS CURRENTLY A DRAFT AND IS NOT YET COMPLETE
Measure: NQF 0052 (Additional Measure)
Measure Title: Low Back Pain: Use of Imaging Studies
Measure Description: The percentage of patients with a primary diagnosis of low back pain and who did not have an imaging study (plain X‐ray, MRI, CT scan) within 28 days of diagnosis.
*REQUIRED FOR MEANINGFUL USE (MU) ADDITIONAL CQM MEASURE: Click here to view Meaningful Use Criteria.
-
Updated on: Dec 07, 2022
*NQF 0027 (Additional): Smoking and Tobacco Use Cessation, Medical Assistance
Measure: NQF 0027 (Additional Measure)
Measure Title: Smoking and Tobacco Use Cessation, Medical assistance: a. Advising Smokers and Tobacco Users to Quit, b. Discussing Smoking and Tobacco Use Cessation Medications, c. Discussing Smoking and Tobacco Use Cessation Strategies
Measure Description: The percentage of patients 18 years of age and older who were current smokers or tobacco users, who were seen by a practitioner during the measurement year and who received advice to quit smoking or tobacco use or whose practitioner recommended or discussed smoking or tobacco use cessation medications, methods or strategies.
-
Updated on: Dec 07, 2022
NQF 0084 (Additional): Heart Failure: Warfarin Therapy Patients with Atrial Fibrillation
Measure: NQF 0084 (Additional Measurement)
Measure Title: Heart Failure (HF) : Warfarin Therapy Patients with Atrial Fibrillation
Measure Description: Percentage of all patients aged 18 and older with a diagnosis of heart failure and paroxysmal or chronic atrial fibrillation who were prescribed warfarin therapy.
*REQUIRED FOR MEANINGFUL USE (MU): Click here to view the Meaningful Use Criteria